<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03447275</url>
  </required_header>
  <id_info>
    <org_study_id>EMR 200054-604</org_study_id>
    <nct_id>NCT03447275</nct_id>
  </id_info>
  <brief_title>The Vitamin B Status in Type 2 Diabetes (VITA) Study</brief_title>
  <acronym>VITA</acronym>
  <official_title>The Vitamin B Status in Type 2 Diabetes (VITA) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rima Obeid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck KGaA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Syneed Medidata GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Saarland University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study was to evaluate vitamin B deficiency (particularly vitamin B6
      deficiency) in diabetic patients in Germany in relation to the presence or absence of
      proteinuria, and global vascular risk.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This observational study recruited either control subjects or patients with type 2 diabetes
      for over 5 years and collected information on cardiovascular risk factors. Fasting blood
      samples and urine were collected and biomarkers of B-vitamins were measured and were related
      to renal function or to global cardiovascular risk. Global cardiovascular risk was calculated
      from established models that include Routine clinical and laboratory markers such as plasma
      lipids, smoking, hypertension, and BMI.

      we measured the following markers: Glucose (fasting plasma glucose); HbA1C; serum creatinine;
      Glomerular filtration rate (GFR), urinary Albumin, C-reactive Protein, Soluble vascular cell
      adhesion molecule 1 (sVCAM-1), cystatin C, vitamin B1, vitamin B12, holotranscobalamin,
      methylmalonic acid, homocysteine, and different vitamin B6 forms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2011</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The difference in serum vitamin B12 levels between cases and controls</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare mean levels of the controls with those in the patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The difference in serum vitamin B1 between cases and controls</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare mean levels of the controls with those in the patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The difference in serum vitamin B6 concentrations between cases and controls</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare mean levels of the controls with those in the patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The difference in serum vitamin B12 between patients with and those without albuminuria</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare mean levels of diabetes patients with microalbuminuria and those without microalbuminuria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The difference in serum and urine vitamin B1 between patients with and those without albuminuria</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare mean levels of diabetes patients with microalbuminuria and those without microalbuminuria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The difference in serum and urine vitamin B6 vitamers between patients with and those without albuminuria</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare mean levels of diabetes patients with microalbuminuria and those without microalbuminuria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The difference in serum and urine vitamin B6 vitamers between patients with advanced global vascular risk versus those with a low vascular risk</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare mean levels of diabetes patients with microalbuminuria and those without microalbuminuria</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">174</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Vitamin B 12 Deficiency</condition>
  <condition>Vitamin B 6 Deficiency</condition>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Apparently healthy subjects without type 2 diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with type 2 diabetes</arm_group_label>
    <description>type 2 Diabetes since 5 years or longer</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Type 2 diabetes</intervention_name>
    <description>Test if patients with diabetes have different blood concentrations of vitamin biomarkers compared with control subjects and if vitamin levels in the patients will differ according to renal damage.</description>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_label>Patients with type 2 diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        122 patients with type 2 Diabetes and 52 control subjects were recruited (50% women in both
        groups).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Written informed consent before any study-related activities

          2. Ambulatory subject &gt;18 years of age

             For patients with type 2 Diabetes:

          3. Duration of diabetes â‰¥ 5 years

          4. Glycated haemoglobin (HbA1C) &lt;10%

          5. Body mass index (BMI) 19-40 kg/m2

             For healthy controls:

          6. No diabetes (normal fasting glucose levels measured by stick)

        Exclusion Criteria:

          1. End stage renal disease (creatinine clearance &lt;10 mL/min)

          2. Severe excess alcohol consumption (&gt;50 units/week)

          3. Severe co-morbidities

          4. Renal and/or pancreatic transplant

          5. Vitamin B1, B6 and/or B12 substitution (incl. multivitamin preparations)

          6. Participation in an interventional study within 30 previous days;

          7. Patient is female and pregnant or lactating

          8. Patient is female in a childbearing age without adequate contraceptive precaution
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wilfred A Nix, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology, Medical University of Mainz, 55131 Mainz, Germany</affiliation>
  </overall_official>
  <link>
    <url>https://linkinghub.elsevier.com/retrieve/pii/S0168-8227(14)00458-6</url>
    <description>Journal Website</description>
  </link>
  <results_reference>
    <citation>Nix WA, Zirwes R, Bangert V, Kaiser RP, Schilling M, Hostalek U, Obeid R. Vitamin B status in patients with type 2 diabetes mellitus with and without incipient nephropathy. Diabetes Res Clin Pract. 2015 Jan;107(1):157-65. doi: 10.1016/j.diabres.2014.09.058. Epub 2014 Oct 8.</citation>
    <PMID>25458341</PMID>
  </results_reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2018</study_first_submitted>
  <study_first_submitted_qc>February 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2018</study_first_posted>
  <last_update_submitted>May 7, 2018</last_update_submitted>
  <last_update_submitted_qc>May 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Saarland University</investigator_affiliation>
    <investigator_full_name>Rima Obeid</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Vitamin B 12 Deficiency</mesh_term>
    <mesh_term>Vitamin B 6 Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>data will not be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

